Bacterial cell wall biosynthesis machinery

The bacterial cell wall biosynthesis machinery is a coordinated system of enzymes and proteins responsible for the assembly and maintenance of the peptidoglycan layer, a vital structural component of the bacterial cell envelope (Silhavy et al., 2010, Cold Spring Harb Perspect Biol) [1]. This machinery operates across multiple cellular compartments, beginning in the cytoplasm with the Mur family of enzymes (MurA-F) that synthesize the UDP-MurNAc-pentapeptide precursor (Silver, 2011, Clin Microbiol Rev) [2]. These precursors are then transferred to the cell membrane by MraY and MurG to form Lipid I and Lipid II, which are flipped across the membrane by flippases such as MurJ (Sham et al., 2014, Science) [3]. On the exterior surface, penicillin-binding proteins (PBPs) catalyze the transglycosylation and transpeptidation reactions that polymerize and cross-link the glycan chains, providing the cell with osmotic stability and shape (Sauvage et al., 2008, FEMS Microbiol Rev) [4]. Because this machinery is essential for bacterial survival and lacks a human homolog, it is one of the most successful targets for antibiotic therapy (Kohanski et al., 2010, Nat Rev Microbiol) [5]. Drugs such as beta-lactams and glycopeptides disrupt this process, leading to cell wall weakening, osmotic lysis, and bacterial death (Munita & Arias, 2016, Microbiol Spectr) [6]. However, the clinical utility of these drugs is increasingly challenged by the emergence of resistance mechanisms, such as the production of beta-lactamases or the modification of target binding sites (Silver, 2011, Clin Microbiol Rev) [2].

Other names

Peptidoglycan biosynthesis pathwayMurein synthesis machineryCell wall assembly complexCell wall synthesis

Inhibition of MurA enzyme; inhibition of D-alanine metabolism; inhibition of lipid carrier recycling; sequestration of peptidoglycan precursors; and inhibition of transpeptidation via binding to penicillin-binding proteins (PBPs).